G01N 2800/108
Osteoporosis
G01N2800/108 (Osteoporosis) appears on 147 US grants and 187 published applications in this corpus.
Search patents in G01N- Granted patents
- 147
- Published applications
- 187
- Assignees
- 107
- Inventors
- 378
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 13 | 0 |
| 1998 | 2 | 0 |
| 1999 | 8 | 0 |
| 2000 | 11 | 0 |
| 2001 | 4 | 1 |
| 2002 | 5 | 3 |
| 2003 | 2 | 12 |
| 2004 | 3 | 9 |
| 2005 | 3 | 10 |
| 2006 | 2 | 9 |
| 2007 | 4 | 12 |
| 2008 | 3 | 10 |
| 2009 | 7 | 16 |
| 2010 | 7 | 18 |
| 2011 | 10 | 8 |
| 2012 | 9 | 12 |
| 2013 | 5 | 15 |
| 2014 | 11 | 4 |
| 2015 | 5 | 8 |
| 2016 | 3 | 9 |
| 2017 | 5 | 3 |
| 2018 | 2 | 6 |
| 2019 | 2 | 3 |
| 2020 | 1 | 2 |
| 2021 | 1 | 2 |
| 2022 | 2 | 4 |
| 2023 | 0 | 6 |
| 2024 | 2 | 0 |
| 2025 | 1 | 2 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for treating bone mineralization disorders28 Apr 2026US 12,611,447 B2Alexion Pharmaceuticals, Inc.
- Bone turnover markers adjustment24 Feb 2026US 12,560,615 B2Endocrinology and Metabolism Research Institute
- Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening21 Jan 2025US 12,203,940 B2Lyfstone B.V.
- Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening19 Nov 2024US 12,146,885 B2Lyfstone B.V.
- Method for inducing osteogenic differentiation2 Jan 2024US 11,859,209 B2Kyoto University
- System and method for assessing a risk of bone loss in a patient1 Oct 2026US 2026/0301951 A1
- Antibody or antigen-binding fragment thereof binding to ß-ctx and kit thereof11 Jun 2026US 2026/0159576 A1Hytest Ltd.
- Compositions and methods utilizing a novel human foxo3 isoform16 Apr 2026US 2026/0102465 A1New York Society for the Relief of the Ruptured and Crippled, maintaining the Hospital for Special S
- Biglycan peptide and antibodies28 Aug 2025US 2025/0271450 A1SGPTH Life Science AB
- Natural matrix mixture for the treatment of bone fragility17 Jul 2025US 2025/0228900 A1Bios-Therapy, Physiological Systems for Health S.p.A.
Most cited
By later US patents
- Compounds and therapies for the prevention of vascular and non-vascular pathologies146US 6,117,911 ANeoRx Corporation · 2000
- Compounds and therapies for the prevention of vascular and non-vascular pathologies61US 6,410,587 B1NeoRx Corporation · 2002
- Antibodies specific for sclerostin56US 7,578,999 B2Celltech R&D Limited · 2009
- Detection of collagen degradation in vivo55US 5,320,970 AWashington Research Foundation · 1994
- Peptide fragments containing HP and LP cross-links46US 5,140,103 AWashington Research Foundation · 1992